The effect of thiamine deficiency on inflammation, oxidative stress and cellular migration in an experimental model of sepsis
Tóm tắt
Sepsis is a prevalent condition in critically ill patients and may be associated with thiamine deficiency (TD). The aim of this study was to evaluate the effect of TD on inflammation, oxidative stress and cellular recruitment in a sepsis model. The experimental sepsis model, cecal ligation and puncture (CLP), was utilized on mice in comparison with a sham procedure. The following four groups were compared against each other: SHAM with AIN93G complete chow, SHAM with thiamine deficient (TD) chow, CLP with AIN93G complete chow, and CLP with TD chow. Thiamine pyrophosphate (TPP) blood concentrations were determined, and blood and peritoneal fluid were evaluated for differences in TNF-alpha, IL-1, IL-6, KC and MCP-1/CCL2 levels. In addition, the levels of 4-HNE adducts in liver proteins were evaluated by Western Blot. The mean TPP blood concentration from the mice fed with the complete chow was 303.3 ± 42.6 nmol/L, and TD occurred within 10 days. TNF-α and MCP-1 concentrations in the peritoneal fluid were significantly greater in the CLP with TD chow group when compared with the other groups. The blood IL-1β level, however, was lower in the CLP with TD chow group. Liver 4-HNE levels were highest in the TD chow groups. Blood mononuclear cell numbers, as well as peritoneal total leukocyte, mononuclear cell and neutrophil numbers were greater in the CLP with TD chow group. Peritoneal bacterial colony forming units (CFU) were significantly lower in the CLP with TD chow group. TD was associated with greater bacterial clearance, oxidative stress and inflammatory response changes.
Tài liệu tham khảo
American College of Chest Physicians/Society of Critical Care Medicine: Consensus conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992, 20: 864-874. 10.1097/00003246-199206000-00025.
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001, 345: 1368-1377. 10.1056/NEJMoa010307.
Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2008, 36 (1): 296-327. 10.1097/01.CCM.0000298158.12101.41.
Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, Mayer K, Oppert M, Olthoff D, Quintel M, Ragaller M, Rossaint R, Stuber F, Weiler N, Welte T, Bogatsch H, Hartog C, Loeffler M, Reinhart K: Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med. 2007, 33 (4): 606-618. 10.1007/s00134-006-0517-7.
Záhorec R, Firment J, Straková J, Mikula J, Malík P, Novák I, Zeman J, Chlebo P: Epidemiology of severe sepsis in intensive care units in the Slovak Republic. Infection. 2005, 33 (3): 122-128. 10.1007/s15010-005-4019-2.
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002.
Sales Júnior JAL, David CM, Hatum R, Souza PCSP, Japiassú AM, Cleovaldo TS, Pinheiro CTS, Friedman G, Silva OB, Dias MDA, Koterba E, Dias FS, Piras C, Luiz RR: Sepse Brasil: epidemiological study of sepsis in intensive care units brazilian. Braz J Intensive Care. 2006, 18 (1): 9-17.
Silva E, Pedro MA, Sogayar AC, Mohovic T, Silva CL, Janiszewski M, Cal RG, de Sousa EF, Abe TP, de Andrade J, de Matos JD, Rezende E, Assunção M, Avezum A, Rocha PC, de Matos GF, Bento AM, Corrêa AD, Vieira PC, Knobel E: Brazilian Sepsis Epidemiological Study (BASES study). Crit Care. 2004, 8 (4): 251-260. 10.1186/cc2892.
Soriano FG: Sepsis: Celular, Tissue and Organ Alterations In Experimental Model Of Sepsis. Role of Cytokines and Gene Expression. PhD Thesis. 2006, São Paulo University: Medicine School
Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, De Backer D, Hedenstierna G, Joannidis M, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H: Cardiovascular, infections, pneumonia and sepsis, critical care organization and outcome, education, ultrasonography, metabolism and coagulation. Intensive Care Med. 2012, 38 (3): 345-358. 10.1007/s00134-012-2467-6.
Sogayar AMC, Machado FR, Rea-Neto A, Dornas A, Grion CMC, Lobo SMA: Prospective study to evaluate costs of septic patients in brazilian intensive care units. Pharmacoecon. 2008, 26 (5): 425-434. 10.2165/00019053-200826050-00006.
Butterworth RF: Thiamine. Modern Nutrition in Health and Disease. Edited by: Shils ME. 2006, Lippincott: Williams & Wilkins, 426-433. 10
Mclain AL, Szweda PA, Szweda LI: α-Ketoglutarate dehydrogenase: a mitochondrial redox sensor. Free Radic Res. 2011, 45 (1): 29-36. 10.3109/10715762.2010.534163.
Donnino MW, Carney E, Cocchi MN, Barbash I, Chase M, Joyce N, Chou PP, Ngo L: Thiamine deficiency in critically ill patients with sepsis. J Crit Care. 2010, 25: 576-581. 10.1016/j.jcrc.2010.03.003.
Manzanares W, Hardy G: Thiamine supplementation in the critically ill. Curr Opin Clin Nutr Metab Care. 2011, 14 (6): 610-617. 10.1097/MCO.0b013e32834b8911.
Lima LFP, Leite HP, Taddei JAAC: Low blood thiamine concentrations in children upon admission to the intensive care unit: risk factors and prognostic significance. Am J Clin Nutr. 2011, 93 (1): 57-61. 10.3945/ajcn.2009.29078.
Schoenenberger AW, Schoenenberger-Berzins R, Maur C, Suter M, Vergopoulos A, Erne M: Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study. Clin Res Cardiol. 2012, 101: 159-164. 10.1007/s00392-011-0376-2.
Sriram K, Manzanares W, Joseph K: Thiamine in nutrition therapy. Nutr Clin Pract. 2012, 27 (1): 41-50. 10.1177/0884533611426149.
Azizi-Namini P, Ahmed M, Yan AT, Keith M: The role of B vitamins in the management of heart failure. Nutr Clin Pract. 2012, 27 (3): 363-374. 10.1177/0884533612444539.
Cunha S, Cunha JB, Salles JB, Silva MC, Cunha Bastos VL, Mandarim-De-Lacerda CA: Cardiac alterations in furosemide-treated thiamine-deprived rats. J Card Fail. 2007, 13 (9): 774-784. 10.1016/j.cardfail.2007.06.729.
Gioda CR, Barreto TO, Prímola-Gomes TN, De Lima DC, Campos PP, Capettini LS, Lauton-Santos S, Vasconcelos AC, Coimbra CC, Lemos VS, Pesquero JL, Cruz JS: Cardiac oxidative stress is involved in heart failure induced by thiamine deprivation in rats. Am J Physiol Heart Circ Physiol. 2010, 298: 2039-2045. 10.1152/ajpheart.00820.2009.
Wang Y, Cheng J, Chen G, Rob F, Naseem RH, Ngyen L, Johnstone JL, Hill JA: Remodeling of outward K+ currents in pressure-overload heart failure. J Cardiovasc Electrophysiol. 2007, 18 (2): 869-875.
Wang JJL, Hua Z, Fentress HM, Singleton CK: JNK1 is inactivated during thiamine deficiency-induced apoptosis in human neuroblastoma cells. J Nutr Biochem. 2000, 11: 208-215. 10.1016/S0955-2863(00)00067-X.
Hazell AS: Astrocytes are a major target in thiamine deficiency and Wernicke’s encephalopathy. Neurochem Int. 2009, 55 (1): 129-135.
Hazell AS, Butterworth RF: Update of cell damage mechanisms in thiamine deficiency: focus on oxidative stress, excitotoxicity and inflammation. Alcohol Alcohol. 2007, 44 (2): 141-147.
Hirsch JA, Parrott J: New considerations on the neuromodulatory role of thiamine. Pharmacology. 2012, 89 (1–2): 111-116.
Karuppagounder SS, Xu H, Shi Q, Chen LH, Pedrini S, Pechman D, Baker H, Beal MF, Gandy SE, Gibson GE: Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer’s mouse model. Neurobiol Aging. 2009, 30 (10): 1587-1600. 10.1016/j.neurobiolaging.2007.12.013.
Wang X, Wang B, Fan Z, Shi X, Ke ZJ, Luo J: Thiamine deficiency induces endoplasmic reticulum stress in neurons. Neuroscience. 2007, 144: 1045-1056. 10.1016/j.neuroscience.2006.10.008.
Lindenbaum GA, Larrieu AJ, CarrolL SF, Kapusnick RA: Effect of cocarboxylase in dogs subjected to experimental septic shock. Crit Care Med. 1989, 17 (10): 1036-1040. 10.1097/00003246-198910000-00014.
Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT: Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care. 2007, 11 (2): 49-10.1186/cc5783.
Delves RPJ, Roitt D: The immune system - first of two parts. N Engl J Med. 2000, 343: 37-50. 10.1056/NEJM200007063430107.
Janeway CA, Medzhitov R: Innate immunity recognition. Annu Rev Immunol. 2002, 20: 197-216. 10.1146/annurev.immunol.20.083001.084359.
Cerwenka A, Lanier LL: Natural killer cells, viruses and cancer. Nat Rev Immunol. 2001, 1: 41-49. 10.1038/35095564.
Mosser DM, Edwards JP: Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008, 8: 958-969. 10.1038/nri2448.
Andriantsitohaina R, Duluc L, García-Rodríguez JC, GIL-Del Valle L, Guevara-Garcia M, Simard G, Soleti R, Su DF, Velásquez-Pérez L, Wilson JX, Laher I: Systems biology of antioxidants. Clin Sci. 2012, 123 (3): 173-192. 10.1042/CS20110643.
Andrades ME, Arian Morina A, Spasić S, Spasojević I: Bench-to-bedside review: sepsis - from the redox point of view. Crit Care. 2011, 15 (5): 230-10.1186/cc10334.
Raza H, John A: 4-Hydroxynonenal induces mitochondrial oxidative stress, apoptosis and expression of glutathione S -transferase A4-4 and cytochrome P450 2E1 in PC12 cells. Toxicol Appl Pharmacol. 2006, 216 (2): 309-318. 10.1016/j.taap.2006.06.001.
Zhang Y, Sano M, Shinmolura K, Tamaki K, Katsumata Y, Matsuhashi T, Morizane S, Ito H, Hishiki T, Endo J, Zhou H, Yuasa S, Kaneda R, Suematsu M, Fukuda K: 4-Hydroxy-2-nonenal protects against cardiac ischemia-reperfusion injury via the Nrf2-dependent pathway. J Mol Cell Cardiol. 2010, 49: 576-586. 10.1016/j.yjmcc.2010.05.011.
Sano M: Cardioprotection by hormetic responses to aldehyde. Circ J. 2010, 74: 1787-1793. 10.1253/circj.CJ-10-0716.
Wicherman KA, Baue AE, Chaudry IH: Sepsis and septic shock - a review of laboratory models and a proposal. J Surg Res. 1980, 29: 189-201. 10.1016/0022-4804(80)90037-2.
Remick DG, Peter AW: Evaluation of endotoxin models for the study of sepsis. Shock. 2005, 24 (1): 7-11.
Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Loring W, Rue I, Chaudry IH: Cecal ligation and puncture. Shock. 2005, 24 (1): 52-57.
Esmon CT: Why do animal models (sometimes) fail to mimic human sepsis?. Crit Care Med. 2004, 32: 219-222. 10.1097/01.CCM.0000127036.27343.48.
Rittirsch D, Hoesel LM, Ward A: The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol. 2007, 81: 137-143.
Machado CJS, Filipecki ATP, Teixeira MO: Current Brazilian law on animal experimentation. Science. 2009, 324 (5935): 1643-1644. 10.1126/science.324_1643.
Reeves PG, Nielsen FH, Fahey JRGC: AIN-93 purified diets for laboratory rodents: final report of the american institute of nutrition ad hoc writing committee on the reformulation of the ain-76a rodent diet. J Nutr. 1993, 123: 1939-1951.
Gomes RN: Therapeutical Potential Of The Paf Acetilhidrolase (Paf-Ah) In The Control Of Sepsis. Thesis. 2006, Rio de Janeiro: Oswaldo Cruz Institute
Lu J, Frank EL: Rapid HPLC measurement of thiamine and its phosphate esters in whole blood. Clin Chem. 2008, 54 (5): 901-906. 10.1373/clinchem.2007.099077.
Kurisaki E, Hiraiwa K: Western blot analysis for 4-hydroxy-2-nonenal (HNE)-modified proteins in paraquat-treated mice. Legal Med. 2009, 11: 431-433.
Zar J: Biostatistical analysis. 1999, Prentice Hall: Upper Saddle River, 4
Bozza FA, Bozza PT, Faria-Neto HC: Beyond sepsis pathophysiology with cytokines: what is their value as biomarkers for disease severity?. Mem Inst Oswaldo Cruz. 2005, 100: 217-221.
Catalá A: Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem Phys Lipids. 2009, 157: 1-11. 10.1016/j.chemphyslip.2008.09.004.
Gomes RN, Teixeira-Cunha MG, Figueiredo RT, Almeida PE, Alves SC, Bozza PT, Bozza FA, Bozza MT, Zimmerman GA, Castro-Faria-Neto HC: Bacterial clearance in septic mice is modulated by MCP-1/CCL2 and nitric oxide. Shock. 2013, 39 (1): 63-69.